Fundz

Bio Age Labs reported raising $194 Million in an initial SEC Form D filing, from an offering of $194 Million

PUBLIC · BIOAFeb 13, 2024

Amount Raised

$194 Million

$194 Million sold, per SEC Form D (first sale Feb 1, 2024)

Round Type

Venture

RichmondBiotechnologyHealth CareTherapeutics

Quick answer

BioAge Labs raised $194 Million in a funding round, dated February 1, 2024. BioAge Labs is based in Richmond, California, United States.

How much did BioAge Labs raise?
BioAge Labs raised $194 Million in a funding round on February 1, 2024.
What does BioAge Labs do?
BioAge Labs is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases.
Where is BioAge Labs based and how big is it?
BioAge Labs is based in Richmond, California, United States.
Who are the decision-makers at BioAge Labs?
Fundz holds 1 contact at BioAge Labs. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as BioAge Labs that raised within 45 days of this round, from Fundz verified event records.

  • Lexeo Therapeutics raised $95M on March 15, 2024.
  • Tessera Defense & Homeland Security Inc. raised $62M on March 15, 2024.
  • Noa Therapeutics raised $2.2M (Pre-Seed) on March 13, 2024.
  • Aprea Therapeutics raised $34M (Post-IPO Equity) on March 12, 2024.
  • VolitionRx raised $100K (Pre-Seed) on March 12, 2024.
  • MAIA Biotechnology raised $2.9M (Seed) on March 11, 2024.

Who to call at BioAge Labs, and when

A new round usually means BioAge Labs is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day BioAge Labs raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at BioAge Labs, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at BioAge Labs. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

BioAge Labs

Location

Richmond, California, United States

About

BioAge Labs is a clinical-stage biotechnology company that is harnessing the biology of human aging to develop novel targets and therapies for metabolic diseases. The company’s lead program, azelaprag, is a potential first-in-class oral APJ agonist entering Phase 2 trials in combination with tirzepatide for the treatment of obesity in older adults.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment BioAge Labs raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for BioAge Labs's next move

See what Strategic adds

BioAge Labs raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.